Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers

Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Capecchi, Riccardo, Migliorini, Paola, Zanzi, Federico, Maltinti, Simona, Puxeddu, Ilaria, de Bortoli, Nicola, Bellini, Massimo, Costa, Francesco, Marchi, Santino, Bertani, Lorenzo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8062917/
https://ncbi.nlm.nih.gov/pubmed/33897440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.654319
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia